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Abstract
Background:  Bacillus thuringiensis Cry1Aa insecticidal protein is the most active known B.
thuringiensis toxin against the forest insect pest Lymantria dispar (gypsy moth), unfortunately it is also
highly toxic against the non-target insect Bombyx mori (silk worm).
Results: Surface exposed hydrophobic residues over domains II and III were targeted for site-
directed mutagenesis. Substitution of a phenylalanine residue (F328) by alanine reduced binding to
the Bombyx mori cadherin by 23-fold, reduced biological activity against B. mori by 4-fold, while
retaining activity against Lymantria dispar.
Conclusion: The results identify a novel receptor-binding epitope and demonstrate that virtual
elimination of binding to cadherin BR-175 does not completely remove toxicity in the case of B.
mori.
Background
In the final chapter of her landmark book, Silent Spring,
Rachael Carson recommended Bacillus thuringiensis as a
biological pesticide with less environmental impact than
conventional chemical pesticides [1]. For 30 years B. thur-
ingiensis formulations have been sprayed as topical pesti-
cides with annual world-wide applications estimated at
2.3 × 106 kg [2], providing a massive experiment on its
ecological and health impact. The results have demon-
strated the general safety of B. thuringiensis for the envi-
ronment and humans. The latest application method is
the genetic engineering of plants to systemically express B.
thuringiensis insecticidal proteins. This step increases spe-
cificity and generally has reduced sprayed pesticide impact
on the environment in the United States and Canada.
The report of the sensitivity of monarch butterfly
(Daneaus plexippus) to pollen of genetically modified corn
[3], albeit controversial [4], and unlikely to be a threat to
insects in the field [5-8] reemphasizes what has been
known for almost 100 years [9], B. thuringiensis, despite a
generally narrow host range [10], can affect certain non-
target insects [11]; and the silkworm, Bombyx mori is a
prime example [12,13].
Previous studies have indicated that surface exposed
charged and hydrophobic residues in domains II loop
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regions of several Cry toxins are involved in receptor bind-
ing (irreversible and reversible) [14-18]. This prompted us
to investigate the implications that hydrophobic residues
in other areas on the surface of domain II may affect tox-
icity and binding. Cry1Aa was chosen because of its
known structure [19]; and its high activity to both B. mori
and the forest pest L. dispar. Phenylalanines at position
313, 328, 333, 335, and 461 were selected and tested for
biological activity against B. mori, and L. dispar. Binding to
brush border membrane vesicles (BBMV) and purified
receptors of those insects were investigated.
Methods
Mutant construction
To construct Cry1Aa mutants, Bacillus thuringiensis
cry1Aa1 gene (NCBI accession M11250) from pOS4101
[20], originally from pES1 [21] was subcloned into plas-
mid pBluescript SK(-) to generate pBN-1Aa. To accommo-
date the NdeI fragment containing cry1Aa coding region,
EcoRV recognition sequence in the multiple cloning site
of the vector was modified to NdeI recognition sequence
by site-directed mutagenesis.
The Cry1Aa mutant toxins were constructed using single
strand DNA of the wild type Cry1Aa as template. Muta-
genic oligonucleotide DNA primers were synthesized
from GeneMed Synthesis, Inc. (South San Francisco, CA).
Single strand DNA template was prepared using Bio-Rad
Mutagene mutagenesis kit and site-directed mutagenesis
was performed according to manufacturer's instruction.
DNA sequencing reactions were performed in the PTC-
150 Minicycler (MJ Research, Inc., MA) using the Perkin-
Elmer Applied Biosystems DNA sequencing kit following
manufacturer's instruction. The sequencing results were
analyzed by ABI 373A DNA sequencer.
Protein purification
The crystal inclusion bodies of the Cry1Aa and its mutant
toxins were expressed and purified from E. coli MV1190
containing pBN-1Aa as described [22]. The purified crys-
tal proteins were solubilized in 50 mM Na2CO3 contain-
ing 10 mM DTT, pH 9.6 at 37°C with shaking at 220 rpm
for 5 h. The solubilized protoxin was digested with 2%
(w/w) trypsin (Sigma) at 37°C for 3 h, at a trypsin/pro-
toxin ratio of 1:20 by mass. When obvious incomplete
digestion was observed after visualizing on SDS-10 %
polyacrylamide gels, the protoxins were further digested
with an additional dose of 1 % (w/w) trypsin for 2 h. Tox-
ins were further purified as the monomeric fraction on a
Hiload 16/60 Superdex 200 Prep Grade column (GE
Healthcare) in either HBS (HEPES-buffered saline, 10 mM
Hepes, pH 7.4, 150 mM NaCl, 3.4 mM EDTA) for Biacore
analysis, or 20 mM phosphate buffer, pH 7.4 with an Äkta
Explorer FPLC (GE Healthcare). To ensure toxin existed as
a monomer in solution, dynamic light scattering for
molecular size detection was employed using a DynaPro
801 (Protein Solutions, Inc.). Concentration of protoxins
and toxins was estimated by Coomassie Protein Assay
Reagent (Pierce) and the purity was examined on the SDS-
10 % PAGE [23].
Toxicity bioassays
L. dispar eggs were kindly provided by Gary Bernon (U.S.
Department of Agriculture, Otis Methods Development
Center, Beltsville, MD). Eggs were hatched and reared on
artificial diet (Bio-Serv, Frenchtown, NJ). B. mori eggs were
kindly provided by Ross Milne (Canadian Forestry Serv-
ice, Sault Ste. Marie, Ontario, Canada). Eggs were hatched
and reared on mulberry (Morus albus) leaves from trees
received from the Canadian Forestry Service, Sault Ste.
Marie, Ontario, Canada) and grown in the College of Bio-
logical Sciences Entomology Greenhouse. Insects were
reared at ambient temperature and humidity. Activities of
toxins were determined with 2–3 day old L. dispar and B.
mori  larvae by the surface contamination method as
described [24] and [20], respectively, using trypsin acti-
vated, column purified monomeric toxin. Toxins were
diluted in 50 mM sodium carbonate buffer (pH 9.5), and
50 μg samples were applied per well (2 cm2) on artificial
diet in 24-well tissue culture plates. Two larvae were
placed in each well and the mortality was recorded after 5
days. Bioassays were repeated at least 4 times. The effective
dose estimates (LC50, 50% lethal concentration of toxin)
were calculated using PROBIT analysis [25].
BBMV binding assays
Mutant toxins were tested for binding to brush border
membrane vesicle (BBMV) of B. mori. The BBMVs were
prepared from midguts of the last instar larvae of B. mori,
by the magnesium precipitation method as described
[26]. Twenty μg of toxin was iodinated with 1 mCi of
Na125I (Amersham) in 50 mM sodium carbonate buffer
(pH 9.5) in the presence of one IODO-BEAD (Pierce).
Incubation was for 15 min at room temperature. Labeled
toxins were separated from the unlabeled free iodine
using the Excellulose GF-5 column (Pierce). The specific
activity of the labeled Cry1Aa was 0.75 μCi/μg protein.
Heterologous competition binding assays were performed
as described previously [22]. Ten μg of BBMV (amounts of
BBMV refers to BBMV protein throughout) was incubated
with 2 nM of 125I-labeled toxins in 100 μl of 8 mM
NaHPO4, 2 mM KH2PO4, 150 mM NaCl, pH 7.4, contain-
ing 0.1 % BSA, for 1 h at room temperature in the presence
of increasing amounts of corresponding unlabeled com-
petitors (from 0 to 500 nM). The bound toxins were sep-
arated from unbound toxins by centrifugation at 15,500
rpm (22,000 × g) for 10 min. The pellet containing the
bound toxins was washed twice with binding buffer, andBMC Biochemistry 2008, 9:3 http://www.biomedcentral.com/1471-2091/9/3
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the radioactivity in the resulting pellet was counted in a
gamma counter (Beckman).
Receptor purification
Purified B. mori aminopeptidase N and cadherin-like pro-
tein were obtained from B. mori midguts that were dis-
sected from 4th or 5th instar larvae. BBMV were prepared by
the general method of Wolfersberger [27] as described
[22]. B. mori BBMV (10 mg in 10 ml) was solubilized in 5
mg/ml CHAPS zwitterionic detergent (Roche) overnight
at 4°C with gentle rocking. Solubilized BBMV was centri-
fuged at 10,000 × g for 10 min and supernatant was con-
centrated to 2 ml by Amicon YM30 ultrafiltration. The
sample was loaded on a Q Sepharose HR 10/30 anion-
exchange column with an ÄKTA Explorer (GE Healthcare)
after column activation. A salt gradient (0–1 M NaCl was
used to elute BBMV proteins. The low salt buffer (buffer
A) consisted of 20 mM Tris, 5 mM MgCl, 0.4 mg/ml
CHAPS, pH 8.6, and the high salt buffer used was buffer A
+ 1 M NaCl. All fractions were tested for APN activity by
the LpNA assay. Briefly, 390 μl of sample are mixed with
10 μl of 2 mM leucine-p-nitroanalide (containing a leu-
cine-phenylalanine dipeptide). A yellow chromophoric
change indicates aminopeptidase N activity, defined as
the ability to cleave a neutral amino acid from the N-ter-
minus of a polypeptide. Cry1Aa binding ability was also
checked by slot blotting fractions to PVDF membrane and
probing with biotinylated Cry1Aa [28]. Biotinylation was
done with a Biotin Labeling Kit (Roche). Fractions with
Cry1Aa-binding ability and APN activity were concen-
trated and loaded on a HiLoad 16/60 Superdex 200 Prep
Grade column (GE Healthcare) (120 ml bed volume).
Fractions eluting around 120 kDa, the MW of APN, were
collected, concentrated by Amicon (Millipore) ultrafiltra-
tion on YM30 membranes, and protease inhibitor was
added before freezing. Several kinds of APNs occur in the
midgut of B. mori [29]. Our preparation may contain
more than one of these. Anion-exchange fractions with
Cry1Aa-binding ability but without APN activity were also
size-purifed, and fractions eluting around 175–250 kDa,
the MW of BtR175, were collected and stored. Addition-
ally, the purified fractions were loaded on a 6% SDS-
PAGE gel, then transferred overnight at 40 V to PVDF. The
membrane was probed with biotin-Cry1Aa and biotin-
Cry1Aa F328A. Cry1Aa bound to a single band at 120 kDa
in the APN fraction and a single band at 201 kDa in the
cadherin fraction. Cry1Aa F328A bound only to a single
120 kDa band in the APN fraction but bound no observ-
able bands in the cadherin fraction.
Surface plasmon resonance with purified midgut receptors
B. mori APN and B. mori cadherin were immobilized
(100–200 ng for each) on three flowcells of a single CM5
sensor chip by the amine-coupling method (Biacore AB).
Receptors were diluted into ammonium acetate, pH 4.2
prior to immobilization. An HBS (pH 7.4) buffer (dis-
cribed above under Protein Purification) flow rate of 50
μl/min was used for all injections. Randomized toxin con-
centrations varying from 100 nM to 1000 nM were
injected (110 μl) over the receptor surfaces. Surfaces were
regenerated with 6 μl pulses of 10 mM NaOH, 250 μM
ethylene glycol, pH 11.0 at 100 μl/min. Flowcell 4 (blank)
responses were subtracted from all response curves and
data were fitted using BIAevaluation 3.0. The curves were
fit to a simple 1:1 Langmuir binding model to obtain
apparent rate constants (A + B ↔ AB).
Results and discussion
To investigate the role of surface hydrophobic residues on
receptor binding, the mutant proteins, F313A, F328A, and
F461A; and, the double mutant protein, F333A-F335A,
were expressed at similar levels to that of wild type Cry1Aa
(35–50% total cell protein [20]) and produced stable
toxin peptides by trypsin activation. Stability refers here to
the trypsin resistant state of the 65 kDa toxin. Another
alanine mutant toxin, F338A, was expressed at a low level
or was degraded during trypsin activation (no further
studies were conducted with this mutant). The positions
of these residues on the surface of the Cry1Aa toxin struc-
ture are shown (Fig. 1).
Toxicity of wild type Cry1Aa and mutant toxins against L.
dispar, and B. mori larvae are given in Table 1 as LC50 val-
ues of each toxin. Against L. dispar, none of the mutant
proteins show significant differences in toxicity. To B.
mori, mutant toxin F328A displayed four-fold reduced
toxicity, while F313A, the double mutant F333A-F335A,
and F461A displayed overlapping confidence limits with
the wild type Cry1Aa toxin.
To investigate the mechanism by which mutant protein
F328A reduces toxicity to B. mori, we examined toxin-
binding properties to BBMV. BBMV competition binding
assays of wild type Cry1Aa and mutant toxins demon-
strated that F328A exhibited little competition with the
wild type toxin until the highest amounts of competing
toxins. This reduced affinity is consistent with its reduced
toxicity. Mutant proteins F313A, F461A, and the double
mutant, F333A-F335A, toxins displayed slightly decreased
binding affinity compared to the wild type Cry1Aa (Fig.
2).
We further examined binding properties of these mutant
proteins to the purified known B. mori Cry1Aa binding
proteins from the B. mori midgut. Previous studies dem-
onstrated the purification of Cry1Aa binding proteins
(receptors), aminopeptidase N (APN) and cadherin-like
receptor, from B. mori [12,13]. We have previously exam-
ined binding of Cry1Aa, Cry1Ab, Cry1Ac and hybrid
domain-substitution mutants involving Cry1Aa andBMC Biochemistry 2008, 9:3 http://www.biomedcentral.com/1471-2091/9/3
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Cry1Ac by the surface plasmon resonance with purified B.
mori binding proteins [30]. We found that Cry1Aa binds
to B. mori cadherin-like proteins with a Kd of 2.6 nM and
to B. mori APN with a Kd of 75 nM. Binding of Cry1Ab
and Cry1Ac was negligible to either one of these binding
proteins. Domain substitutions indicated that domain III
from Cry1Ac did not affect binding, indicating that either
the binding epitopes of domain III from Cry1Aa and
Cry1Ac are the same or that they play little role in binding
the cadherin-like proteins.
In this study, we purified both of these binding proteins
from B. mori midgut tissue and analyzed binding proper-
Structure of Cry1Aa insecticidal protein showing surface phenylalanine residues (red) which were changed to alanine Figure 1
Structure of Cry1Aa insecticidal protein showing surface phenylalanine residues (red) which were changed to alanine. A, ribbon diagram 
model to illustrate the secondary structure of domains I (alpha helical), II (beta strands) and III (beta sandwich). B, space filling model, to illustrate the sur-
face exposure of the phenylalanine residues (red). Molecular models were generated using QUANTA (Molecular Simulations, Inc.)
AB
Domain II Domain II
Domain I Domain I
Domain III
Phe461
Phe328
Phe333/335
Phe313
Domain III
Table 1: Biological activities of Cry1Aa and mutant toxins to L. 
dispar, and B. mori. Toxicity is measured as LC50 in ng/ccm.
Toxin LC50 against L. dispar LC50 against B. mori
Cry1Aa (Wt) 1.59 (0.76–2.64) 10.45 (7.14–14.12)
F313A 1.68 (0.86–2.72) 17.34 (11.70–21.74)
F328A 1.80 (0.98–2.80) 41.52 (24.69–66.76)
FF333,335AA 2.18 (1.30–3.26) 15.47 (8.8–25.5)
F461A 1.73 (1.18–2.46) 17.1 (12.7–22.7)
Competition with labeled Cry1Aa and mutant toxins to B.  mori brush border membrane vesicles (BBMV) (bars repre- sent error of n = 4) Figure 2
Competition with labeled Cry1Aa and mutant toxins to B. mori 
brush border membrane vesicles (BBMV) (bars represent error 
of n = 4). Cry1Aa wild type protein, ( - ); F313A mutant protein, (-); 
F333A-F335A, mutant protein (Ќ-Ќ); F461A mutant protein, (-); and, 
F328A mutant protein, ( - ). % uncompeted toxin indicates the % of 
labeled toxin remaining bound to BBMV in the presence of unlabeled cold 
toxin competitor.
nM cold toxin
0.1 1 10 100 1000
%
 
u
n
c
o
m
p
e
t
e
d
 
t
o
x
i
n
0
20
40
60
80
100
120BMC Biochemistry 2008, 9:3 http://www.biomedcentral.com/1471-2091/9/3
Page 5 of 8
(page number not for citation purposes)
ties of wild type and mutant proteins using surface plas-
mon resonance on a BIAcore 2000 (Fig. 3). The wild type
Cry1Aa binding to cadherin-like receptor was ka = 1.3 ×
104 M-1s-1 (+/- 6.1 × 103), kd = 3.3 × 10-5 s -1 (+/- 1x10-5),
KD= 2.6 nM; and to B. mori APN were 2.1 × 104 M-1s-1 (+/
- 1.3 × 102), kd = 1.5 × 10-3s-1 (+/- 1 × 10-5), KD = 75 nM.
Mutant protein F328A showed significantly lower binding
to cadherin-like receptor but bound slightly less (2-fold
lower) to APN than wild type. Its binding to B. mori APN
was 1.8 × 104 M-1s-1 (+/- 2.9 × 102), kd = 2.3 × 10-3 s-1, and
KD = 132 mM; while to B. mori cadherin, the F328A
mutant toxin yielded apparent rate constant values to cad-
nerin: ka = 1.5 × 10 3 M-1s-1 (+/- 9.0 × 10 3), kd = 9.1 × 10-
5 s-1 (+/- 8 × 10-9), KD = 60.7 nM, a 23-fold lower binding
affinity than wild type Cry1Aa. This receptor binding data
suggested that the phenylalanine residue at 328 might
play an important role in binding to the cadherin-like
receptor, which led to the reduction in toxicity. Other
mutant toxins, F313A, F333A-F335A, and F461A did not
show any changes in binding to either APN or cadherin-
like receptor(data not shown).
The cadherin-like protein has been reported to be a func-
tional Cry1Ab receptor [31-34], while APN was reported
as a functional receptor for Cry1Ac [35-37] and Cry1C
[38]. More recently an additional receptor, BR-270, has
been reported as an anionic brush border membrane gly-
coconjugate that show tight binding to a number of Cry
toxins [39]. The role of this receptor in the overall mecha-
nism of action of Cry toxins is unknown and its response
to mutant toxins is unreported. It is possible that only one
of these is a functional receptor, leading to lethality, while
the others serve as non-functional toxin-binding mole-
Binding of Cry1Aa and the mutant toxin F328A to the APN and cadherin-like protein purified from B. mori measured by surface  plasmon resonance (SPR) using a Biacore 1000 Figure 3
Binding of Cry1Aa and the mutant toxin F328A to the APN and cadherin-like protein purified from B. mori measured by surface plas-
mon resonance (SPR) using a Biacore 1000. Representative BIAcore response curves for toxin injections at 200 (lower curve), 300 (second curve 
from bottom), 500 (third curve from bottom), and 1000 nM (top curve). Experimental curves (grey) are shown overlaid with fitted curves (black) obtained 
with the 1:1 Langmuir binding model. The same APN-bound chip is used in figures A and B, and the cadherin-bound chip is used in figures C and D. (A) 
Cry1Aa wt binding to B. mori APN. (B) F328A binding to B. mori APN. (C) Cry1Aa wt binding to B. mori cadherin-like protein. (D) F328A binding to B. mori 
cadherin-like protein.BMC Biochemistry 2008, 9:3 http://www.biomedcentral.com/1471-2091/9/3
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cules. Or, perhaps a more complicated, multifaceted
mechanism is involved, as proposed recently [40].
One unexpected finding in these experiments was that
F461A, F313A and F333A-F335A mutant toxins did not
change the binding properties to either APN or cadherin-
like proteins (not shown), although these mutant pro-
teins did affect overall binding to BBMV. This may be due
to the possibility that these mutations might affect bind-
ing to a binding protein other than APN and the cadherin-
like protein. Taking into account the fact that F313 is
located on a different face from F333 and F335 as indi-
cated in the Fig 1, it is suggested that these phenylalanine
residues might be involved in binding to different recep-
tors or different binding steps.
After the work on this paper was completed we became
aware of a paper [41] reporting a B. thuringiensis strain,
AF101, which exhibited lower activity toward B. mori. The
authors reported that an altered Cry1Ab toxin, responsi-
ble for the lower activity, differed in three residues and the
carboxy-terminal portion from wild type Cry1Ab. The
three residues were S261A (a partially buried residue),
S560N and F328L, the critical residue found in our work
with the different Bt toxin, Cry1Aa. Since Cry1Ab does not
bind significantly to APN or cadherin [30], one might
speculate that F328 may also interact with other receptors.
Our observation that mutation in F328 to A affected bind-
ing to B. mori cadherin but not to L. dispar cadherin indi-
cates that different toxin-receptor interactions take place
in different insects. This principle was noted earlier in
comparing the action of mutants of Cry1Ab and their
action on Manduca sexta and Heliothis virescens [24].
Our understanding of certain aspects of the function of
the B. thuringiensis insecticidal proteins, especially in the
area of receptor binding has also been enhanced by pro-
tein engineering techniques [10,42-44]. Briefly, the previ-
ously described receptor-binding epitopes, best
understood in Cry1Ac, are in the loops at the bottom of
domain II, and N-acetylgalactosamine binding pocket in
domain III [43-45].
Protein engineering techniques have allowed improve-
ments of proteins as well as understanding of their func-
tion [46]. Improvements in toxicity against target pests, as
much as 36-fold, have been reported for B. thuringiensis
toxins [47-49]. In the present paper we demonstrate the
proof of principle that site-specific mutagenesis can
render these biopesticides more specific by reducing activ-
ity to a non-target insect.
Conclusion
In the present paper, we have observed a new receptor-
binding epitope around residue 328 in domain II,
between the previously observed epitopes. Mutations in
this region specifically reduced toxicity 4-fold to B. mori
by blocking binding to B. mori cadherin, BTR175, whereas
binding to B. mori APN was unaffected. The results dem-
onstrate that virtual elimination of binding to cadherin
BR-175 does not completely remove toxicity in the case of
B. mori.
Through a combination of learning more about the mech-
anism of action of these biopesticides, rational applica-
tion of protein engineering techniques and serendipity,
better insecticidal proteins can be developed that have
improved activity against target pests and reduced activity
against certain non-target insects. The overall aim in this
effort is to protect agricultural crops and reduce non-spe-
cific pesticides to achieve increased food production while
protecting the environment.
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